The research team projects that the Ultra-low Molecular Weight Heparin (ULMWH) market size will grow from XXX in 2019 to XXX by 2026, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2026.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Hepalink
Bioiberica
Opocrin
Changshan Pharm
King-friend Biochemical Pharmaceutical
Qianhong Bio-pharma
Jiulong Biochemicals
Aspen Oss
Pfizer
Dongcheng Biochemicals
Tiandong
Deebio
Xinbai
Yino Pharma Limited
By Type
Oral
Parenteral
By Application
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Ultra-low Molecular Weight Heparin (ULMWH) 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Ultra-low Molecular Weight Heparin (ULMWH) Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the Ultra-low Molecular Weight Heparin (ULMWH) Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ultra-low Molecular Weight Heparin (ULMWH) market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Ultra-low Molecular Weight Heparin (ULMWH) Revenue 1.5 Market Analysis by Type 1.5.1 Global Ultra-low Molecular Weight Heparin (ULMWH) Market Size Growth Rate by Type: 2020 VS 2026 1.5.2 Oral 1.5.3 Parenteral 1.6 Market by Application 1.6.1 Global Ultra-low Molecular Weight Heparin (ULMWH) Market Share by Application: 2021-2026 1.6.2 Treatment of Venous Thromboembolism 1.6.3 Complications of Pregnancy 1.6.4 Cardioversion of Atrial Fibrillation/Flutter 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Ultra-low Molecular Weight Heparin (ULMWH) Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter's Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Ultra-low Molecular Weight Heparin (ULMWH) Market Players Profiles 3.1 Hepalink 3.1.1 Hepalink Company Profile 3.1.2 Hepalink Ultra-low Molecular Weight Heparin (ULMWH) Product Specification 3.1.3 Hepalink Ultra-low Molecular Weight Heparin (ULMWH) Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.2 Bioiberica 3.2.1 Bioiberica Company Profile 3.2.2 Bioiberica Ultra-low Molecular Weight Heparin (ULMWH) Product Specification 3.2.3 Bioiberica Ultra-low Molecular Weight Heparin (ULMWH) Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.3 Opocrin 3.3.1 Opocrin Company Profile 3.3.2 Opocrin Ultra-low Molecular Weight Heparin (ULMWH) Product Specification 3.3.3 Opocrin Ultra-low Molecular Weight Heparin (ULMWH) Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.4 Changshan Pharm 3.4.1 Changshan Pharm Company Profile 3.4.2 Changshan Pharm Ultra-low Molecular Weight Heparin (ULMWH) Product Specification 3.4.3 Changshan Pharm Ultra-low Molecular Weight Heparin (ULMWH) Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.5 King-friend Biochemical Pharmaceutical 3.5.1 King-friend Biochemical Pharmaceutical Company Profile 3.5.2 King-friend Biochemical Pharmaceutical Ultra-low Molecular Weight Heparin (ULMWH) Product Specification 3.5.3 King-friend Biochemical Pharmaceutical Ultra-low Molecular Weight Heparin (ULMWH) Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.6 Qianhong Bio-pharma 3.6.1 Qianhong Bio-pharma Company Profile 3.6.2 Qianhong Bio-pharma Ultra-low Molecular Weight Heparin (ULMWH) Product Specification 3.6.3 Qianhong Bio-pharma Ultra-low Molecular Weight Heparin (ULMWH) Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.7 Jiulong Biochemicals 3.7.1 Jiulong Biochemicals Company Profile 3.7.2 Jiulong Biochemicals Ultra-low Molecular Weight Heparin (ULMWH) Product Specification 3.7.3 Jiulong Biochemicals Ultra-low Molecular Weight Heparin (ULMWH) Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.8 Aspen Oss 3.8.1 Aspen Oss Company Profile 3.8.2 Aspen Oss Ultra-low Molecular Weight Heparin (ULMWH) Product Specification 3.8.3 Aspen Oss Ultra-low Molecular Weight Heparin (ULMWH) Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.9 Pfizer 3.9.1 Pfizer Company Profile 3.9.2 Pfizer Ultra-low Molecular Weight Heparin (ULMWH) Product Specification 3.9.3 Pfizer Ultra-low Molecular Weight Heparin (ULMWH) Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.10 Dongcheng Biochemicals 3.10.1 Dongcheng Biochemicals Company Profile 3.10.2 Dongcheng Biochemicals Ultra-low Molecular Weight Heparin (ULMWH) Product Specification 3.10.3 Dongcheng Biochemicals Ultra-low Molecular Weight Heparin (ULMWH) Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.11 Tiandong 3.11.1 Tiandong Company Profile 3.11.2 Tiandong Ultra-low Molecular Weight Heparin (ULMWH) Product Specification 3.11.3 Tiandong Ultra-low Molecular Weight Heparin (ULMWH) Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.12 Deebio 3.12.1 Deebio Company Profile 3.12.2 Deebio Ultra-low Molecular Weight Heparin (ULMWH) Product Specification 3.12.3 Deebio Ultra-low Molecular Weight Heparin (ULMWH) Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.13 Xinbai 3.13.1 Xinbai Company Profile 3.13.2 Xinbai Ultra-low Molecular Weight Heparin (ULMWH) Product Specification 3.13.3 Xinbai Ultra-low Molecular Weight Heparin (ULMWH) Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.14 Yino Pharma Limited 3.14.1 Yino Pharma Limited Company Profile 3.14.2 Yino Pharma Limited Ultra-low Molecular Weight Heparin (ULMWH) Product Specification 3.14.3 Yino Pharma Limited Ultra-low Molecular Weight Heparin (ULMWH) Production Capacity, Revenue, Price and Gross Margin (2015-2020) 4 Global Ultra-low Molecular Weight Heparin (ULMWH) Market Competition by Market Players 4.1 Global Ultra-low Molecular Weight Heparin (ULMWH) Production Capacity Market Share by Market Players (2015-2020) 4.2 Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Market Share by Market Players (2015-2020) 4.3 Global Ultra-low Molecular Weight Heparin (ULMWH) Average Price by Market Players (2015-2020) 5 Global Ultra-low Molecular Weight Heparin (ULMWH) Production by Regions (2015-2020) 5.1 North America 5.1.1 North America Ultra-low Molecular Weight Heparin (ULMWH) Market Size (2015-2020) 5.1.2 Ultra-low Molecular Weight Heparin (ULMWH) Key Players in North America (2015-2020) 5.1.3 North America Ultra-low Molecular Weight Heparin (ULMWH) Market Size by Type (2015-2020) 5.1.4 North America Ultra-low Molecular Weight Heparin (ULMWH) Market Size by Application (2015-2020) 5.2 East Asia 5.2.1 East Asia Ultra-low Molecular Weight Heparin (ULMWH) Market Size (2015-2020) 5.2.2 Ultra-low Molecular Weight Heparin (ULMWH) Key Players in East Asia (2015-2020) 5.2.3 East Asia Ultra-low Molecular Weight Heparin (ULMWH) Market Size by Type (2015-2020) 5.2.4 East Asia Ultra-low Molecular Weight Heparin (ULMWH) Market Size by Application (2015-2020) 5.3 Europe 5.3.1 Europe Ultra-low Molecular Weight Heparin (ULMWH) Market Size (2015-2020) 5.3.2 Ultra-low Molecular Weight Heparin (ULMWH) Key Players in Europe (2015-2020) 5.3.3 Europe Ultra-low Molecular Weight Heparin (ULMWH) Market Size by Type (2015-2020) 5.3.4 Europe Ultra-low Molecular Weight Heparin (ULMWH) Market Size by Application (2015-2020) 5.4 South Asia 5.4.1 South Asia Ultra-low Molecular Weight Heparin (ULMWH) Market Size (2015-2020) 5.4.2 Ultra-low Molecular Weight Heparin (ULMWH) Key Players in South Asia (2015-2020) 5.4.3 South Asia Ultra-low Molecular Weight Heparin (ULMWH) Market Size by Type (2015-2020) 5.4.4 South Asia Ultra-low Molecular Weight Heparin (ULMWH) Market Size by Application (2015-2020) 5.5 Southeast Asia 5.5.1 Southeast Asia Ultra-low Molecular Weight Heparin (ULMWH) Market Size (2015-2020) 5.5.2 Ultra-low Molecular Weight Heparin (ULMWH) Key Players in Southeast Asia (2015-2020) 5.5.3 Southeast Asia Ultra-low Molecular Weight Heparin (ULMWH) Market Size by Type (2015-2020) 5.5.4 Southeast Asia Ultra-low Molecular Weight Heparin (ULMWH) Market Size by Application (2015-2020) 5.6 Middle East 5.6.1 Middle East Ultra-low Molecular Weight Heparin (ULMWH) Market Size (2015-2020) 5.6.2 Ultra-low Molecular Weight Heparin (ULMWH) Key Players in Middle East (2015-2020) 5.6.3 Middle East Ultra-low Molecular Weight Heparin (ULMWH) Market Size by Type (2015-2020) 5.6.4 Middle East Ultra-low Molecular Weight Heparin (ULMWH) Market Size by Application (2015-2020) 5.7 Africa 5.7.1 Africa Ultra-low Molecular Weight Heparin (ULMWH) Market Size (2015-2020) 5.7.2 Ultra-low Molecular Weight Heparin (ULMWH) Key Players in Africa (2015-2020) 5.7.3 Africa Ultra-low Molecular Weight Heparin (ULMWH) Market Size by Type (2015-2020) 5.7.4 Africa Ultra-low Molecular Weight Heparin (ULMWH) Market Size by Application (2015-2020) 5.8 Oceania 5.8.1 Oceania Ultra-low Molecular Weight Heparin (ULMWH) Market Size (2015-2020) 5.8.2 Ultra-low Molecular Weight Heparin (ULMWH) Key Players in Oceania (2015-2020) 5.8.3 Oceania Ultra-low Molecular Weight Heparin (ULMWH) Market Size by Type (2015-2020) 5.8.4 Oceania Ultra-low Molecular Weight Heparin (ULMWH) Market Size by Application (2015-2020) 5.9 South America 5.9.1 South America Ultra-low Molecular Weight Heparin (ULMWH) Market Size (2015-2020) 5.9.2 Ultra-low Molecular Weight Heparin (ULMWH) Key Players in South America (2015-2020) 5.9.3 South America Ultra-low Molecular Weight Heparin (ULMWH) Market Size by Type (2015-2020) 5.9.4 South America Ultra-low Molecular Weight Heparin (ULMWH) Market Size by Application (2015-2020) 5.10 Rest of the World 5.10.1 Rest of the World Ultra-low Molecular Weight Heparin (ULMWH) Market Size (2015-2020) 5.10.2 Ultra-low Molecular Weight Heparin (ULMWH) Key Players in Rest of the World (2015-2020) 5.10.3 Rest of the World Ultra-low Molecular Weight Heparin (ULMWH) Market Size by Type (2015-2020) 5.10.4 Rest of the World Ultra-low Molecular Weight Heparin (ULMWH) Market Size by Application (2015-2020) 6 Global Ultra-low Molecular Weight Heparin (ULMWH) Consumption by Region (2015-2020) 6.1 North America 6.1.1 North America Ultra-low Molecular Weight Heparin (ULMWH) Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Ultra-low Molecular Weight Heparin (ULMWH) Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Ultra-low Molecular Weight Heparin (ULMWH) Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Ultra-low Molecular Weight Heparin (ULMWH) Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Ultra-low Molecular Weight Heparin (ULMWH) Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Ultra-low Molecular Weight Heparin (ULMWH) Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Ultra-low Molecular Weight Heparin (ULMWH) Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Ultra-low Molecular Weight Heparin (ULMWH) Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Ultra-low Molecular Weight Heparin (ULMWH) Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Ultra-low Molecular Weight Heparin (ULMWH) Consumption by Countries 7 Global Ultra-low Molecular Weight Heparin (ULMWH) Production Forecast by Regions (2021-2026) 7.1 Global Forecasted Production of Ultra-low Molecular Weight Heparin (ULMWH) (2021-2026) 7.2 Global Forecasted Revenue of Ultra-low Molecular Weight Heparin (ULMWH) (2021-2026) 7.3 Global Forecasted Price of Ultra-low Molecular Weight Heparin (ULMWH) (2021-2026) 7.4 Global Forecasted Production of Ultra-low Molecular Weight Heparin (ULMWH) by Region (2021-2026) 7.4.1 North America Ultra-low Molecular Weight Heparin (ULMWH) Production, Revenue Forecast (2021-2026) 7.4.2 East Asia Ultra-low Molecular Weight Heparin (ULMWH) Production, Revenue Forecast (2021-2026) 7.4.3 Europe Ultra-low Molecular Weight Heparin (ULMWH) Production, Revenue Forecast (2021-2026) 7.4.4 South Asia Ultra-low Molecular Weight Heparin (ULMWH) Production, Revenue Forecast (2021-2026) 7.4.5 Southeast Asia Ultra-low Molecular Weight Heparin (ULMWH) Production, Revenue Forecast (2021-2026) 7.4.6 Middle East Ultra-low Molecular Weight Heparin (ULMWH) Production, Revenue Forecast (2021-2026) 7.4.7 Africa Ultra-low Molecular Weight Heparin (ULMWH) Production, Revenue Forecast (2021-2026) 7.4.8 Oceania Ultra-low Molecular Weight Heparin (ULMWH) Production, Revenue Forecast (2021-2026) 7.4.9 South America Ultra-low Molecular Weight Heparin (ULMWH) Production, Revenue Forecast (2021-2026) 7.4.10 Rest of the World Ultra-low Molecular Weight Heparin (ULMWH) Production, Revenue Forecast (2021-2026) 7.5 Forecast by Type and by Application (2021-2026) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026) 7.5.2 Global Forecasted Consumption of Ultra-low Molecular Weight Heparin (ULMWH) by Application (2021-2026) 8 Global Ultra-low Molecular Weight Heparin (ULMWH) Consumption Forecast by Regions (2021-2026) 8.1 North America Forecasted Consumption of Ultra-low Molecular Weight Heparin (ULMWH) by Country 8.2 East Asia Market Forecasted Consumption of Ultra-low Molecular Weight Heparin (ULMWH) by Country 8.3 Europe Market Forecasted Consumption of Ultra-low Molecular Weight Heparin (ULMWH) by Countriy 8.4 South Asia Forecasted Consumption of Ultra-low Molecular Weight Heparin (ULMWH) by Country 8.5 Southeast Asia Forecasted Consumption of Ultra-low Molecular Weight Heparin (ULMWH) by Country 8.6 Middle East Forecasted Consumption of Ultra-low Molecular Weight Heparin (ULMWH) by Country 8.7 Africa Forecasted Consumption of Ultra-low Molecular Weight Heparin (ULMWH) by Country 8.8 Oceania Forecasted Consumption of Ultra-low Molecular Weight Heparin (ULMWH) by Country 8.9 South America Forecasted Consumption of Ultra-low Molecular Weight Heparin (ULMWH) by Country 8.10 Rest of the world Forecasted Consumption of Ultra-low Molecular Weight Heparin (ULMWH) by Country 9 Global Ultra-low Molecular Weight Heparin (ULMWH) Sales by Type (2015-2026) 9.1 Global Ultra-low Molecular Weight Heparin (ULMWH) Historic Market Size by Type (2015-2020) 9.2 Global Ultra-low Molecular Weight Heparin (ULMWH) Forecasted Market Size by Type (2021-2026) 10 Global Ultra-low Molecular Weight Heparin (ULMWH) Consumption by Application (2015-2026) 10.1 Global Ultra-low Molecular Weight Heparin (ULMWH) Historic Market Size by Application (2015-2020) 10.2 Global Ultra-low Molecular Weight Heparin (ULMWH) Forecasted Market Size by Application (2021-2026) 11 Global Ultra-low Molecular Weight Heparin (ULMWH) Manufacturing Cost Analysis 11.1 Ultra-low Molecular Weight Heparin (ULMWH) Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Ultra-low Molecular Weight Heparin (ULMWH) 12 Global Ultra-low Molecular Weight Heparin (ULMWH) Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Ultra-low Molecular Weight Heparin (ULMWH) Distributors List 12.3 Ultra-low Molecular Weight Heparin (ULMWH) Customers 12.4 Ultra-low Molecular Weight Heparin (ULMWH) Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer
| Price : US$ 3500 | Date : Apr 2024 |
| Category : Manufacturing and Construction | Pages : 114 |
| Price : US$ 2450 | Date : Apr 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 261 |
| Price : US$ 3500 | Date : Mar 2024 |
| Category : Chemicals and Materials | Pages : 180 |
| Price : US$ 3500 | Date : Mar 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 174 |
| Price : US$ 3500 | Date : Mar 2024 |
| Category : Medical Devices | Pages : 233 |
We will be happy to help you find what you need. Please call us or write to us:
Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).
This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection
Request Sample 
Request Discount 
Inquire Before Buy
